詹琼医生简介

詹琼，女，肿瘤学硕士，现任华山医院肿瘤科副主任医师，在肿瘤内科有丰富的临床经验，主持上海自然科学基金项目，以第一作者身份在国内外核心期刊发表论文10余篇。
特色治疗：在良、恶性肿瘤的微波，射频和聚焦超声（HIFU）治疗方面有丰富的经验。

中国医药教育协会肿瘤转移专业委员会委员兼秘书长
上海市医学会分子诊断专科分会第二届委员会青年委员
上海市抗癌协会第一届青年理事会理事
上海市抗癌协会脑转移瘤专业委员会常委兼秘书
上海市抗癌协会肿瘤免疫治疗专业委员会委员
北京医学奖励基金会脑转移瘤专委会委员
上海抗癌协会疑难肿瘤专委会委员

2019 上海抗癌协会科技奖三等奖

国内外期刊发表多篇论文。、
1. Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients. Yang L, Yan X, Chen J, Zhan Q, Hua Y, Xu S, Li Z, Wang Z, Dong Y, Zuo D, Xue M, Tang Y, Herschman HR, Lu S, Shi Q, Wei W. Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2012228118. IF 12.5
2. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis. Huang R, Ge M, Zhou X, Ji X, Liao L, Liang X, Zhan Q. Cancer Biother Radiopharm. 2019 Mar;34(2):128-133. IF 3.35
3. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases. Ge M, Zhuang Y, Zhou X, Huang R, Liang X, Zhan Q. J Neurooncol. 2017 Nov;135(2):413-418.
4. Comparison of internal target volumes defined by three-dimensional, four-dimensional, and cone-beam computed tomography images of a motion phantom. Wang Y, Liu T, Chen H, Bai P, Zhan Q, Liang X.Ann Transl Med. 2020 Nov;8(22):1488. doi: 10.21037/atm-20-6246.
5. 梁晓华, 黄若凡, 詹琼. 驱动基因阳性非小细胞肺癌脑转移诊治上海专家共识(2019年版)[J]. 中国癌症杂志, 2019, 29(01):76-85.
6. Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.Ge M, Zhan Q, Zhang Z, Ji X, Zhou X, Huang R, Liang X. BMC Cancer. 2019 Feb 12;19(1):143.
7. Efficacy and safety of bevacizumab combined with chemotherapy in symptomatic brain metastases from lung adenocarcinoma: a retrospective analysis. Zhan Q, Miao F, Huang R, Zhou X, Ge M, Liang X. J Thorac Dis. 2019 Nov;11(11):4725-4734.
8. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases. Huang R, Xu X, Li D, Chen K, Zhan Q, Ge M, Zhou X, Liang X, Guan M. Target Oncol. 2019 Jun;14(3):343-350.
9. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients. Liao L, Yu H, Ge M, Zhan Q, Huang R, Ji X, Liang X, Zhou. Thorac Cancer. 2019 May;10(5):1203-1212.
10. PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways. Liao L, Ge M, Zhan Q, Huang R, Ji X, Liang X, Zhou X. Int J Biol Sci. 2019 Jan 1;15(1):183-194.
11. Characterization of genetic alterations in brain metastases from non-small cell lung cancer. Liao L, Ji X, Ge M, Zhan Q, Huang R, Liang X, Zhou X.FEBS Open Bio. 2018 Aug 30;8(9):1544-1552.
12. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram. Ji X, Zhuang Y, Yin X, Zhan Q, Zhou X, Liang X. BMC Cancer. 2017 Nov 21;17(1):774.